Coral Laboratories Limited

CORALAB.BO·BSE
Compare
524.00+9.75 (+1.89%)today
As of Oct 22, 9:40 AM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close514.25
Open531.00
Day range524.00531.00
52-week range360.00679.00
Off day high−1.32%
Off 52-week high−22.83%
Volume4.00
Avg. volume (3M)1.41K
Market cap1.87B
EPS (TTM)53.76
Forward P/E9.01
P/E ratio (TTM)9.75
Dividend yield0.39% (2.00)
Beta (5Y)—
Shares outstanding3.57M
Short interest—
Earnings dateAug 12, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
CORALAB.BO MAKERSL.BO 3933.HK BDH.BO AUROLAB.BO JENBURPH.BO
Market cap 1.87B 1.24B 13.59B 2.63B 1.42B 4.01B
P/E (TTM) 9.7 36.4 25.6 23.3 29.9 11.8
Forward P/E 9.0 20.7 10.0 63.3 — 26.1
Price/book 0.9 1.7 0.7 3.4 3.1 2.0
Dividend yield 0.39% — 6.57% 1.09% — 2.31%
1-year change +6.67% +52.22% −44.63% +1.80% +7.72% −14.39%
Today +1.89% +6.24% −4.43% −0.90% −0.57% +1.48%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

What visitors to Coral Laboratories's page also look at.

Company Mkt cap Price Today
JENBURKT PHARMACEUTICALS LTD.JENBURPH.BO 4.01B 909.00 +1.48%
ANUH PHARMA LTD.ANUHPHR.BO 8.01B 79.89 −3.61%
BDH INDUSTRIES LTD.BDH.BO 2.63B 456.00 −0.90%
GUJARAT THEMIS BIOSYN LTD.GUJTHEM.BO 46.22B 355.10 +1.08%
TYCHE INDUSTRIES LTD.TYCHE.BO 1.10B 107.00 +3.68%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All CORALAB.BO news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.